Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laura Sevick"'
Autor:
Mark Hofmeister, Ally Memedovich, Laura E. Dowsett, Laura Sevick, Tamara McCarron, Eldon Spackman, Tania Stafinski, Devidas Menon, Tom Noseworthy, Fiona Clement
Publikováno v:
BMC Palliative Care, Vol 17, Iss 1, Pp 1-7 (2018)
Abstract Background The aim of palliative care is to improve the quality of life of patients and families through the prevention and relief of suffering. Frequently, patients may choose to receive palliative care in the home. The objective of this pa
Externí odkaz:
https://doaj.org/article/cc15a928c0aa4fb6a2be4062968bfd02
Publikováno v:
Medical oncology (Northwood, London, England). 34(9)
Management of human epidermal growth factor receptor-2-positive (HER2+) breast cancer patients includes the combination of adjuvant chemotherapy and trastuzumab. A meta-analysis reported that
Autor:
Ori D. Rotstein, Laura Sevick, Marcus J. Burnstein, R. Hart, Grace H Tang, S. Miller, W. Varatheswaran, S. De Montbrun, Marck Mercado, Nancy N. Baxter, Sergio A. Acuna, Christine Brezden-Masley
Publikováno v:
European Journal of Cancer. 51:S353-S354
Autor:
Maha Hassan, Laura Sevick, Amanda S. Manoharan, Chanele Polenz, Christina Marchand, Ronald Burkes, Christine Brezden Masley
Publikováno v:
Chemotherapy: Open Access.
Autor:
Amanda S. Manoharan, Maha Hassan, Christina Marchand, Christine B. Brezden, Chanele Polenz, Ronald Burkes, Laura Sevick
Publikováno v:
Journal of Clinical Oncology. 31:e17557-e17557
e17557 Background: Optimal treatment of patients with colorectal cancer (CRC) includes the timely administration of adjuvant chemotherapy (AC). While Cancer Care Ontario (CCO) guidelines advise that CRC patients receive their first AC no later than 8
Autor:
Laura Sevick, Christina Marchand, Maha Awaiz Hassan, Rosane Nisenbaum, Delilah Lisa Topic, Audrey Wong, Sophie Hogeveen, Ata Ansari, Christine Brezden-Masley, Jalal Ebrahim, Ammar Bookwala
Publikováno v:
Journal of Clinical Oncology. 31:527-527
527 Background: Cancer Care Ontario (CCO) guidelines advise that colorectal cancer (CRC) patients receive their first adjuvant chemotherapy (AC) no later than 8 weeks after surgical resection, with new data suggesting optimal treatment to commence be
Autor:
Ammar Bookwala, Daisy Dastur, Ata Ansari, Jalal Ebrahim, Audrey Wong, Christina Marchand, Christine B. Brezden, Sophie Hogeveen, Laura Sevick
Publikováno v:
Journal of Clinical Oncology. 30:36-36
36 Background: The medical specialty of oncology relies heavily on clinical trials to advance policies and practices related to cancer care. However, oncology clinical trial accrual in Ontario has dropped from 12.4% in 2007, to 8.5% in 2009. The obje
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.